Research Topics
Genomes and Genes | Jaap GoudsmitSummaryAffiliation: Crucell Holland BV Country: The Netherlands Publications
Research Grants
| Collaborators
|
Detail Information
Publications
A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxisJohn de Kruif
Crucell Holland BV, Leiden, The Netherlands
Annu Rev Med 58:359-68. 2007..Using this process as a model, the general requirements for development of safe and efficacious monoclonal antibody alternatives to currently used polyclonal serum products are discussed...
Primary effect of chemotherapy on the transcription profile of AIDS-related Kaposi's sarcomaAntoinette C van der Kuyl
Department of Human Retrovirology, Academic Medical Center, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands
BMC Cancer 2:21. 2002..From in vitro studies it has become clear that these drugs can affect specific genes, as well as have an effect upon the total transcriptome...
Gene expression profile of AIDS-related Kaposi's sarcomaMarion Cornelissen
Department of Human Retrovirology, Academic Medical Centre, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands
BMC Cancer 3:7. 2003..Its course is aggravated by co-infection with HIV-1, where the timing of infection with HIV-1 and HHV8 is important for the clinical outcome...
Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulinJaap Goudsmit
Crucell Holland BV, Leiden, The Netherlands
J Infect Dis 193:796-801. 2006..These results demonstrate that the human MAb cocktail of CR57 and CR4098 is a safe and efficacious alternative to RIG in rabies postexposure prophylaxis...
Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1Ariane Rodriguez
Crucell Holland BV, Archimedesweg 4 6, 2333 CN Leiden, The Netherlands
Infect Immun 76:1709-18. 2008..Our results show the ability of rAd35 to induce potent T-cell immunity in combination with protein in a prime-boost schedule without impairing the B-cell response...
High-level expression from two independent expression cassettes in replication-incompetent adenovirus type 35 vectorRonald Vogels
Crucell Holland BV, PO Box 2048, 2301 CA Leiden, The Netherlands
J Gen Virol 88:2915-24. 2007..Such rAd35 vectors thus expand the utility of rAd35 vaccine carriers for the development of vaccines against, for example, malaria, AIDS and tuberculosis...
Increased immunogenicity of recombinant Ad35-based malaria vaccine through formulation with aluminium phosphate adjuvantOlga J A E Ophorst
Crucell Holland BV, P O Box 2048, 2301 CA Leiden, The Netherlands
Vaccine 25:6501-10. 2007..CS alone. With these results we report for the first time the feasibility of using an AlPO(4) adjuvant to increase the potency of a live adenovirus serotype 35-based vaccine...
Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicityAngelique A C Lemckert
Crucell Holland BV, PO Box 2048, 2301 CA Leiden, The Netherlands
J Gen Virol 87:2891-9. 2006..SIVGag vaccine. These data demonstrate the potential of a replication deficient human group D adenoviral vector for vaccination purposes...
Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferonKatarina Radosevic
Crucell Holland BV, Archimedesweg 4 6, 2333 CN Leiden, The Netherlands
Infect Immun 75:4105-15. 2007..These results unify conflicting reports on the relative importance of CD4 versus CD8 T-cell responses in protection and emphasize the key role of IFN-gamma...
The human antibody repertoire specific for rabies virus glycoprotein as selected from immune librariesR Arjen Kramer
Crucell Holland B.V, Leiden, The Netherlands
Eur J Immunol 35:2131-45. 2005..The obtained specificities expand the set of human anti-RV antibodies eligible for inclusion in an antibody cocktail aimed for use in rabies post-exposure prophylaxis...
Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysisWilfred E Marissen
Crucell Holland BV, Archimedesweg 4, P.O. Box 20482301, CA Leiden, The Netherlands
J Virol 79:4672-8. 2005....
Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeysAriane Rodriguez
Crucell Holland BV, PO Box 2048, 2301 CA Leiden, The Netherlands
Vaccine 27:6226-33. 2009..CS or possibly another adenovector of a distinct serotype, induces a complex immune response that is required for protection against malaria, and is thus a highly promising approach for pediatric vaccination...
Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirusEdward N van den Brink
Crucell Holland BV, PO Box 2048, 2301 CA Leiden, The Netherlands
J Virol 79:1635-44. 2005..The complete set of SARS-CoV MAbs described here may be useful for diagnosis, chemoprophylaxis, and therapy of SARS-CoV infection and disease...
Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5Lennart Holterman
Crucell Holland BV, Leiden, The Netherlands
J Virol 78:13207-15. 2004..We therefore conclude that the Ad11-based vector represents a novel and useful candidate gene transfer vehicle for vaccination and gene therapy...
Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvantsKatarina Radosevic
Crucell Holland BV, Leiden, The Netherlands
Vaccine 26:3640-6. 2008....
Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunityAngelique A C Lemckert
Crucell Holland B. V, Leiden, The Netherlands
J Virol 79:9694-701. 2005..Nevertheless, these data suggest the potential utility of heterologous rAd prime-boost vaccine regimens using vectors derived from rare human Ad serotypes...
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cellsMark Throsby
Crucell Holland BV, Leiden, The Netherlands
PLoS ONE 3:e3942. 2008..Furthermore, there are 16 different HA subtypes and no certainty the next pandemic will be caused by an H5 subtype, thus it is important to develop prophylactic and therapeutic interventions that provide heterosubtypic protection...
Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine developmentMark Throsby
Crucell Holland BV, Leiden, The Netherlands
Expert Rev Vaccines 6:183-91. 2007..This review will give an overview of vaccines under development and summarize current data on E-protein antigenicity that could aid in the design of next generation WNV vaccines...
Validation of the rapid fluorescent focus inhibition test for rabies virus-neutralizing antibodies in clinical samplesStefan Kostense
Crucell Holland BV, Leiden, The Netherlands
Antimicrob Agents Chemother 56:3524-30. 2012..We concluded that the assay is suitable for the measurement of polyclonal and monoclonal rabies neutralizing antibodies in clinical serum samples...
Pre- and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivirWouter Koudstaal
Crucell Holland BV, 2333 CN Leiden, The Netherlands
J Infect Dis 200:1870-3. 2009..These results justify further preclinical evaluation of broadly neutralizing mAbs against influenza virus for the prevention and treatment of influenza virus infections...
Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile VirusMark Throsby
Crucell Holland B V, P O Box 2048, 2301 CA, Leiden, The Netherlands
J Virol 80:6982-92. 2006....
An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicityOlga J A E Ophorst
Crucell Holland BV, P.O. Box 2048, Leiden 2301 CA, The Netherlands
Vaccine 22:3035-44. 2004..We thus conclude that, for ex vivo vaccination, Ad5.Fib35 shows promise as vector for loading of DC but is unable to circumvent anti-Ad5 immunity limiting its in vivo utility...
Expression and immunogenicity of the Plasmodium falciparum circumsporozoite protein: the role of GPI signal sequenceOlga J A E Ophorst
Crucell Holland BV, P O Box 2048, Leiden 2301 CA, The Netherlands
Vaccine 25:1426-36. 2007..Our results show that rational design of antigens is warranted for further development of malaria vaccines...
Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospectsKatarina Radosevic
Immunology and Proof of Concept, Innovation and Discovery Lab, Crucell Holland BV, Leiden, The Netherlands
Expert Rev Vaccines 8:577-92. 2009..This review provides an overview of heterologous prime-boost vaccination modalities currently in development for the 'big three' poverty-related diseases and emphasizes the need for innovative vaccination approaches...
Quantification of residual host cell DNA in adenoviral vectors produced on PER.C6 cellsLinda Gijsbers
Crucell Holland BV, 2301CA Leiden, The Netherlands
Hum Gene Ther 16:393-8. 2005..C6 cells throughout a standard purification process. Because of its specifications, we anticipate that the assay can have broad applicability to biologics other than adenoviral vectors produced on PER.C6 cells...
Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectorsSandra Verhaagh
Crucell Holland BV, Archimedesweg 4, 2333 CN Leiden, The Netherlands
J Gen Virol 87:255-65. 2006..SIVgag vaccine as compared with rAd35.SIVgag exposed dendritic cells from wild-type littermates. It was concluded that MYII mice represent an interesting preclinical model to evaluate potency and safety of rAd35 vectors...
New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferretsRobert H E Friesen
Crucell Holland BV, Leiden, The Netherlands
PLoS ONE 5:e9106. 2010..Here we report the latest efficacy data for a representative antibody of this novel class...
Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vectorStefan Kostense
Crucell Holland BV, Leiden, The Netherlands
AIDS 18:1213-6. 2004..Ad35 is less prone to neutralization than Ad5, encouraging the further development of Ad35 for vaccination against HIV...
Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunityRonald Vogels
Vaccine R and D Division, Crucell Holland BV, 2301CA Leiden, The Netherlands
J Virol 77:8263-71. 2003..We further demonstrate that transduction with Ad35 is not hampered by preexisting Ad5 immunity and that Ad35 efficiently infects dendritic cells, smooth muscle cells, and synoviocytes, in contrast to Ad5...
The Th1 immune response to Plasmodium falciparum circumsporozoite protein is boosted by adenovirus vectors 35 and 26 with a homologous insertKatarina Radosevic
Crucell Holland B V, Archimedesweg 4 6, 2333 CN Leiden, Netherlands
Clin Vaccine Immunol 17:1687-94. 2010..CS/Ad26.CS vaccine at a later age, to induce lasting protection against malaria for which the Th1 response and immune memory is required...
A peptide-based Plasmodium falciparum circumsporozoite assay to test for serum antibody responses to pre-erythrocyte malaria vaccinesStefan Kostense
Crucell Holland, CA Leiden, The Netherlands
Clin Vaccine Immunol 18:776-82. 2011..Antibody titers were in agreement with total antibody responses to the whole CS protein. Due to its simplicity and high performance, the ELISA is an easy and rapid method for assessment of pre-erythrocyte malaria vaccines based on CS...
Plasma HIV-1 RNA to guide patient selection for antiretroviral therapy in resource-poor settings: efficiency related to active case findingJohannes A Bogaards
Department of Human Retrovirology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
J Acquir Immune Defic Syndr 41:232-7. 2006..Plasma viral load testing can ensure a more efficient allocation of antiretroviral therapy but only when applied to a strategy of active case finding in the community...
Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC methodJohan C Kapteyn
Crucell Holland BV, P O Box 2048, 2301 CA Leiden, The Netherlands
Vaccine 24:3137-44. 2006..C6((R)) cell cultures. The RP-HPLC assay selectivity allows for the simultaneous identification and quantification of HA(1) from influenza A and B strains in the yearly revised trivalent vaccines for epidemic outbreaks...
Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutantsJan Ter Meulen
Crucell Holland B V, Leiden, Netherlands
PLoS Med 3:e237. 2006..Combinations of virus-neutralizing, noncompeting mAbs may have these properties...
The potential of targeted antibody prophylaxis in SARS outbreak control: a mathematic analysisJohannes Antonie Bogaards
Crucell Holland BV, PO Box 2048, 2301 CA Leiden, The Netherlands
Travel Med Infect Dis 5:70-8. 2007..If new mutants of SARS coronavirus do initiate another epidemic, administration of prophylactic antibodies to risk groups may supplement the stringent isolation procedures that contained the first SARS outbreak...
Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiberElisabeth H Slager
Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
Cancer Gene Ther 11:227-36. 2004....
PER.C6(®) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccineBarbara P Sanders
Crucell Holland BV, Archimedesweg 4 6, 2333 CN Leiden, The Netherlands
Vaccine 31:850-6. 2013..Based on our findings, we are exploring PER.C6(®) as an interesting platform for large-scale production of poliovirus at low costs, potentially providing the basis for global supply of an affordable IPV...
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferretsJan Ter Meulen
Crucell Holland BV, Leiden, Netherlands
Lancet 363:2139-41. 2004..The data generated in this animal model show that administration of a human monoclonal antibody might offer a feasible and effective prophylaxis for the control of human SARS coronavirus infection...
Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus speciesRoland Zahn
Crucell Holland BV, Leiden, The Netherlands
PLoS ONE 7:e44115. 2012..Combination of the five selected filovirus glycoproteins in one multivalent vaccine potentially elicits protective immunity in man against all major filovirus strains that have caused lethal outbreaks in the last 20 years...
Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectorsMieke C Sprangers
Vaccine R and D Division, Crucell Holland BV, 2301 CA Leiden, The Netherlands
J Clin Microbiol 41:5046-52. 2003..Based on simplicity, speed, high throughput, sensitivity, and robustness, we propose a qualified assay in which Ad neutralization is monitored by luciferase reporter gene expression...
C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemiaAlexander B H Bakker
Crucell Holland B V, Leiden, The Netherlands
Cancer Res 64:8443-50. 2004..The AML reactivity combined with the restricted expression on normal cells identifies CLL-1 as a novel potential target for AML treatment...
Challenges in the search for an HIV vaccineAngelique A C Lemckert
Crucell Holland BV, 2301 CA Leiden, The Netherlands
Eur J Epidemiol 19:513-6. 2004..An immunogen that elicits broadly reactive neutralizing antibodies, however, has yet to be developed...
Low versus high CD4 cell count as starting point for introduction of antiretroviral treatment in resource-poor settings: a scenario-based analysisJohannes A Bogaards
Department of Human Retrovirology, Academic Medical Center, University of Amsterdam, The Netherlands
Antivir Ther 8:43-50. 2003..In a hospital-based setting in resource-poor environments this ensures an efficient treatment allocation...
Prediction of residual time to AIDS and death based on markers and cofactorsRonald B Geskus
Municipal Health Service, Cluster of Infectious Diseases, Nieuwe Achtergracht 100, 1018 WT Amsterdam, The Netherlands
J Acquir Immune Defic Syndr 32:514-21. 2003..In summary, for prognosis, the markers CD4 count, HIV-1 RNA load, and HIV-1 phenotype (at a high CD4 count) are equally important, and the genetic cofactors considered are of no use...
Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in miceDavid R Kaufman
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
J Virol 82:6829-37. 2008..These studies also suggest that rAd vectors warrant further assessment as candidate subunit smallpox vaccines...
Primary HIV-1 subtype C infection in EthiopiaTobias F Rinke de Wit
Ethio-Netherlands AIDS Research Project (ENARP) at the Ethiopian Health and Nutrition Research Institute (EHNRI, Addis Ababa, Ethiopia
J Acquir Immune Defic Syndr 30:463-70. 2002..One subject demonstrated a window period of at least 204 days, combined with a high preseroconversion viral load and no decline of CD4 T cells over a follow-up period of at least 3 years...
Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985-1996Neil Renwick
Department of Human Retrovirology, Academic Medical Center, University of Amsterdam, The Netherlands
J Infect Dis 185:1808-12. 2002..Unlike HIV-1, HBV, or HCV infection, HHV-8 infection is uncommon in Amsterdam drug users, as is HHV-8 transmission through IDU...
Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeysJinyan Liu
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
J Virol 82:4844-52. 2008..Moreover, qualitative differences in cellular immune responses may prove critical in determining the overall potency of heterologous rAd prime-boost regimens...
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunityDan H Barouch
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
J Immunol 172:6290-7. 2004..Moreover, these studies suggest that using Ad vectors derived from immunologically distinct serotypes may be an effective and general strategy to overcome the suppressive effects of pre-existing anti-Ad immunity...
AIDS vaccines that allow HIV-1 to infect and escape immunologic control: a mathematic analysis of mass vaccinationMarijn van Ballegooijen
Institute for Biodiversity and Ecosystem Dynamics, Faculty of Science, University of Amsterdam, The Netherlands
J Acquir Immune Defic Syndr 34:214-20. 2003..The number of long-term survivors is substantially increased only when vaccination is initiated early in an AIDS epidemic, however...
Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccinationDavid R Kaufman
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
J Immunol 181:4188-98. 2008..Thus, i.m. vaccination can overcome immune compartmentalization and generate robust mucosal CD8(+) T lymphocyte memory. These data demonstrate that the systemic and mucosal immune systems are highly coordinated following vaccination...
Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-gamma and antibody responses in miceJoseph P Shott
Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA
Vaccine 26:2818-23. 2008..Here we report that Ad5.CS, Ad35.CS, and RTS,S/AS01B, elicited both cellular and serologic CSP antigen-specific responses in mice. These adenoviral vectors induce strong malaria-specific immunity and warrant further evaluation...
EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc ConsortiumPierre Alexandre Bart
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Vaccine 26:3153-61. 2008..Half of the 10 assessed responded in the ELISpot assay under stringent criteria, which informed the sample size for a DNA-NYVAC-C comparison to NYVAC-C alone...
Viral replication under combination antiretroviral therapy: a comparison of four different regimensAzra C Ghani
Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College of Science, Technology and Medicine, London, UK
J Acquir Immune Defic Syndr 30:167-76. 2002..04; 95% CI, 1.0-1.07). Measurement of viral load after approximately 7 days provided the most accurate measure of the degree of viral suppression induced by a given drug regimen...
The rate of epidemiological and virological changes during the transition from nascent to concentrated HIV epidemic stage in the former Soviet Union countriesAlexey A Nabatov
Department of Molecular Cellular Biology and Immunology, VU Medical Center, Free University Amsterdam, The Netherlands
AIDS Res Hum Retroviruses 23:183-92. 2007....
Affinity ranking of antibodies using flow cytometry: application in antibody phage display-based target discoveryCecilia A W Geuijen
Crucell Holland B.V, P.O. Box 2048, Leiden 2301 CA, The Netherlands
J Immunol Methods 302:68-77. 2005..Finally, we show that a low-affinity antibody may only detect high expression levels of a surface marker while failing to detect lower expression levels of this molecule, which may lead to a false interpretation of antibody specificity...
Recombination of HIV type 1C (C'/C") in Ethiopia: possible link of EthHIV-1C' to subtype C sequences from the high-prevalence epidemics in India and Southern AfricaGeorgios Pollakis
Department of Human Retrovirology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
AIDS Res Hum Retroviruses 19:999-1008. 2003..The possibility that viruses with a C' envelope have a biological advantage over the viruses with a C" envelope should be further investigated in biological and epidemiological studies...
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon proteinShawn M Sumida
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
J Immunol 174:7179-85. 2005..These studies suggest a potential strategy for engineering novel Ad5 vectors to evade dominant Ad5-specific NAbs...
Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of ResearchD Gray Heppner
Walter Reed Army Institute of Research, Department of Immunology, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA
Vaccine 23:2243-50. 2005..Recent safety, immunogenicity, and efficacy trials in the US and Africa are presented, as well as plans for the development of a multi-antigen vaccine...
Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectorsShawn M Sumida
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
J Virol 78:2666-73. 2004..Novel adenovirus vectors that are currently being developed to circumvent the problem of preexisting anti-Ad5 immunity should therefore be designed to evade both humoral and cellular Ad5-specific immune responses...
A proteomic approach to tumour target identification using phage display, affinity purification and mass spectrometryCecilia A W Geuijen
Crucell Holland B.V, P.O. Box 2048, 2301 CA Leiden, The Netherlands
Eur J Cancer 41:178-87. 2005..These experiments demonstrate that phage antibody selection in combination with affinity chromatography and mass spectrometry can be exploited successfully to identify novel antibody target molecules on malignant cells...
Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individualsGeorgios Pollakis
Department of Human Retrovirology, Academic Medical Center, University of Amsterdam, 1066 CX Amsterdam, The Netherlands
J Virol 78:2841-52. 2004..These results indicate that even though R5 subtype C viruses are restrictive for virus replication, the R5-to-X4 phenotype switch can occur and does so in a manner similar to that of subtype B viruses...
Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosisAbeltje M Polstra
Department of Human Retrovirology, Academic Medical Centre, University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
J Med Virol 74:390-6. 2004..Longitudinal serum samples from 19 AIDS-Kaposi's sarcoma patients, ranging from 2 years before KS till 2 years after KS diagnosis were tested. No correlation was found between viral load and progression to KS, or disease stage...
Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutantsAlexander B H Bakker
Crucell Holland B.V, Archimedesweg 4, P.O. Box 2048, 2301 CA Leiden, The Netherlands
J Virol 79:9062-8. 2005..In vitro exposure of RV to the combination of CR57 and CR4098 yielded no escape mutants. In conclusion, a novel combination of human MAbs was discovered suitable to replace RIG...
Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individualMark J Geels
Department of Human Retrovirology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
J Virol 77:12430-40. 2003..These results demonstrate the sequential accumulation of CTL escape in a patient during disease progression, indicating that multiple combinations of T-cell epitopes are required to control viremia...
CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individualsMark J Geels
Department of Human Retrovirology, Academic Medical Centre, University of Amsterdam, The Netherlands
Virology 345:209-19. 2006..This suggests that loss of T-cell reactivity may not be directly linked to HIV-specific CD4(+) T-cell responses but that increased viremia after CTL escape may influence CD4(+) T-helper responses...
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and DPeter Abbink
Research East Room 213, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA
J Virol 81:4654-63. 2007..These studies substantially expand the portfolio of rare serotype rAd vectors that may prove useful as vaccine vectors for the developing world...
Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine aloneV Ann Stewart
Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, MD, USA
Infect Immun 75:2283-90. 2007..The increased T-cell responses induced by the combination of Ad35.CS and RTS,S/AS01B are sustained for at least 6 months postvaccination and may translate to improved and more durable protection against P. falciparum infection in humans...
Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burdenWorkenesh Ayele
Ethio Netherlands AIDS Research Project, Addis Ababa, Ethiopia
J Clin Microbiol 45:891-6. 2007..Measuring the HIV-1 burden from whole blood dried on filter paper provides a suitable alternative for low-technology settings with limited access to refrigeration, as can be found in sub-Saharan Africa...
Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivityAnna R Thorner
Research East Room 213, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
J Virol 80:12009-16. 2006....
Meeting the immense need for HAART in resource-poor settingsJohannes A Bogaards
Departments of Human Retrovirology, Clinical Epidemiology and Biostatistics, University of Amsterdam, Amsterdam, The Netherlands
J Antimicrob Chemother 52:743-6. 2003
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPsNancy J Sullivan
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
PLoS Med 3:e177. 2006..GP can exert cytopathic effects on transfected cells in vitro, and multiple GP forms have been identified in nature, raising the question of which would be optimal for a human vaccine...
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunityDiane M Roberts
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
Nature 441:239-43. 2006..Such chimaeric viral vectors may have important practical implications for vaccination and gene therapy...
Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeysAnjali Nanda
Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, Massachusetts 02215, USA
J Virol 79:14161-8. 2005..Moreover, these studies demonstrate that capsid chimeric rAd vectors can be constructed to combine beneficial immunologic and serologic properties of different Ad serotypes...
Naturally HIV-1 seroconverters with lowest viral load have best prognosis, but in time lose control of viraemiaJaap Goudsmit
Department of Human Retrovirology, Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
AIDS 16:791-3. 2002
Research Grants
- CORE--VECTORJaap Goudsmit; Fiscal Year: 2005..To coordinate preclinical toxicology studies under GLP conditions and prepare IND applications to support the initiation of phase I and phase II clinical trials...
